Your browser doesn't support javascript.
loading
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Vega, Diana Merino; Nishimura, Katherine K; Zariffa, Névine; Thompson, Jeffrey C; Hoering, Antje; Cilento, Vanessa; Rosenthal, Adam; Anagnostou, Valsamo; Baden, Jonathan; Beaver, Julia A; Chaudhuri, Aadel A; Chudova, Darya; Fine, Alexander D; Fiore, Joseph; Hodge, Rachel; Hodgson, Darren; Hunkapiller, Nathan; Klass, Daniel M; Kobie, Julie; Peña, Carol; Pennello, Gene; Peterman, Neil; Philip, Reena; Quinn, Katie J; Raben, David; Rosner, Gary L; Sausen, Mark; Tezcan, Ayse; Xia, Qi; Yi, Jing; Young, Amanda G; Stewart, Mark D; Carpenter, Erica L; Aggarwal, Charu; Allen, Jeff.
Affiliation
  • Vega DM; Friends of Cancer Research, Washington, DC.
  • Nishimura KK; Cancer Research And Biostatistics (CRAB), Seattle, WA.
  • Zariffa N; NMD Group LLC, Bala Cynwyd, PA.
  • Thompson JC; Division of Pulmonary, Allergy and Critical Care Medicine, Thoracic Oncology Group, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Hoering A; Cancer Research And Biostatistics (CRAB), Seattle, WA.
  • Cilento V; Cancer Research And Biostatistics (CRAB), Seattle, WA.
  • Rosenthal A; Cancer Research And Biostatistics (CRAB), Seattle, WA.
  • Anagnostou V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Baden J; Translational Medicine, Bristol Myers Squibb, Princeton, NJ.
  • Beaver JA; Oncology Center of Excellence, Food and Drug Administration (FDA), Silver Spring, MD.
  • Chaudhuri AA; Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO.
  • Chudova D; Department of Genetics, Washington University School of Medicine, St Louis, MO.
  • Fine AD; Department of Computer Science and Engineering, Washington University, St Louis, MO.
  • Fiore J; Siteman Cancer Center, Washington University School of Medicine, St Louis, MO.
  • Hodge R; Guardant Health Inc, Redwood City, CA.
  • Hodgson D; Research and Development, Foundation Medicine Inc, Cambridge, MA.
  • Hunkapiller N; Oncology Development, Bristol Myers Squibb, Princeton, NJ.
  • Klass DM; Late Oncology Statistics, Oncology Biometrics, AstraZeneca, Cambridge, United Kingdom.
  • Kobie J; Translational Medicine, Oncology Research & Development, AstraZeneca, Waltham, MA.
  • Peña C; GRAIL, Menlo Park, CA.
  • Pennello G; During the conduct of this work and development of the manuscript, N.H. was affiliated with GRAIL, Inc; however, is not affiliated with GRAIL, Inc at the time of submission.
  • Peterman N; Assay Development, Roche Sequencing Solutions, Pleasanton, CA.
  • Philip R; Translational Oncology, Early Oncology Statistics, Merck Research Laboratories, Kenilworth, NJ.
  • Quinn KJ; Companion Diagnostics, Oncology Early Development, Merck Research Laboratories, Kenilworth, NJ.
  • Raben D; Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Food and Drug Administration (FDA), Silver Spring, MD.
  • Rosner GL; Foundation Medicine Inc, San Diego, CA.
  • Sausen M; Division of Molecular Genetics, Office of Health Technology 7 (In Vitro Diagnostics and Radiological Health), Food and Drug Administration (FDA), Silver Spring, MD.
  • Tezcan A; Guardant Health Inc, Redwood City, CA.
  • Xia Q; Product Development Oncology, Genentech Inc, South San Francisco, CA.
  • Yi J; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.
  • Young AG; Translational Medicine, Bristol Myers Squibb, Princeton, NJ.
  • Stewart MD; Foundation Medicine Inc, San Diego, CA.
  • Carpenter EL; Product Development Data Sciences, Genentech Inc, South San Francisco, CA.
  • Aggarwal C; Product Development Oncology, Genentech Inc, South San Francisco, CA.
  • Allen J; Research and Development, Foundation Medicine Inc, Cambridge, MA.
JCO Precis Oncol ; 6: e2100372, 2022 08.
Article in En | MEDLINE | ID: mdl-35952319
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Circulating Tumor DNA / Antineoplastic Agents, Immunological / Lung Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: JCO Precis Oncol Year: 2022 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Circulating Tumor DNA / Antineoplastic Agents, Immunological / Lung Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: JCO Precis Oncol Year: 2022 Document type: Article Country of publication: Estados Unidos